Recursion Pharmaceuticals, Inc. (RXRX)
3.185
-0.14
(-4.35%)
USD |
NASDAQ |
Nov 13, 16:00
3.16
-0.02
(-0.78%)
After-Hours: 19:59
Recursion Pharmaceuticals EPS Diluted (Quarterly) : -0.2192 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2192 |
| June 30, 2026 | -0.246 |
| March 31, 2026 | -0.222 |
| December 31, 2025 | -0.2053 |
| September 30, 2025 | -0.363 |
| June 30, 2025 | -0.4119 |
| March 31, 2025 | -0.5027 |
| December 31, 2024 | -0.5324 |
| September 30, 2024 | -0.3392 |
| June 30, 2024 | -0.4027 |
| March 31, 2024 | -0.3871 |
| December 31, 2023 | -0.3988 |
| September 30, 2023 | -0.434 |
| June 30, 2023 | -0.3809 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.3409 |
| December 31, 2022 | -0.3096 |
| September 30, 2022 | -0.3485 |
| June 30, 2022 | -0.3807 |
| March 31, 2022 | -0.3272 |
| December 31, 2021 | -0.3814 |
| September 30, 2021 | -0.2812 |
| June 30, 2021 | -0.2577 |
| March 31, 2021 | -0.1825 |
| December 31, 2020 | -0.1554 |
| September 30, 2020 | -0.1416 |
| June 30, 2020 | -0.1125 |
| March 31, 2020 | -0.1095 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Absci Corp. | -0.1938 |
| Editas Medicine, Inc. | -0.1523 |
| Twist Bioscience Corp. | -0.316 |
| Beam Therapeutics, Inc. | -1.284 |
| AbbVie, Inc. | 2.373 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -119.04M |
| Revenue (Quarterly) | 18.55M |
| Total Expenses (Quarterly) | 137.59M |
| Enterprise Value | 1.305B |
| Gross Profit Margin (Quarterly) | -9.13% |
| Profit Margin (Quarterly) | -641.6% |
| Earnings Yield | -28.02% |
| Normalized Earnings Yield | -28.02 |